Characterization of cellular immune response and innate immune signaling in human and nonhuman primate primary mononuclear cells exposed to Burkholderia mallei

Burkholderia pseudomallei infection causes melioidosis and is often characterized by severe sepsis. Although rare in humans, Burkholderia mallei has caused infections in laboratory workers, and the early innate cellular response to B. mallei in human and nonhuman primates has not been characterized....

Full description

Saved in:
Bibliographic Details
Published inMicrobial pathogenesis Vol. 78; pp. 20 - 28
Main Authors Alam, Shahabuddin, Amemiya, Kei, Bernhards, Robert C., Ulrich, Robert G., Waag, David M., Saikh, Kamal U.
Format Journal Article
LanguageEnglish
Published England Elsevier Ltd 01.01.2015
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Burkholderia pseudomallei infection causes melioidosis and is often characterized by severe sepsis. Although rare in humans, Burkholderia mallei has caused infections in laboratory workers, and the early innate cellular response to B. mallei in human and nonhuman primates has not been characterized. In this study, we examined the primary cellular immune response to B. mallei in PBMC cultures of non-human primates (NHPs), Chlorocebus aethiops (African Green Monkeys), Macaca fascicularis (Cynomolgus macaque), and Macaca mulatta (Rhesus macaque) and humans. Our results demonstrated that B. mallei elicited strong primary pro-inflammatory cytokines (IFN-γ, TNF-α, IL-1β, and IL-6) equivalent to the levels of B. pseudomallei in primary PBMC cultures of NHPs and humans. When we examined IL-1β and other cytokine responses by comparison to Escherichia coli LPS, African Green Monkeys appears to be most responsive to B. mallei than Cynomolgus or Rhesus. Characterization of the immune signaling mechanism for cellular response was conducted by using a ligand induced cell-based reporter assay, and our results demonstrated that MyD88 mediated signaling contributed to the B. mallei and B. pseudomallei induced pro-inflammatory responses. Notably, the induced reporter activity with B. mallei, B. pseudomallei, or purified LPS from these pathogens was inhibited and cytokine production was attenuated by a MyD88 inhibitor. Together, these results show that in the scenario of severe hyper-inflammatory responses to B. mallei infection, MyD88 targeted therapeutic intervention may be a successful strategy for therapy. [Display omitted] •Cellular response to Burkholderia mallei in humans and NHPs has not been previously reported.•B. mallei exposure elicited a strong MyD88-mediated inflammatory cytokine response.•AGM are more responsive to B. mallei compared to Cynomolgus or Rhesus.•AGM could be a model for acute glanders infection and therapeutic efficacy.•MyD88-targeted therapeutic inhibition could limit immune pathogenesis of B. mallei.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0882-4010
1096-1208
DOI:10.1016/j.micpath.2014.11.009